CABOT CORP — Board/Management Information 2017

Sep 11, 2017

8-K 1 htm_55334.htm LIVE FILING CoverPageHeader start html PUBLIC "-//W3C//DTD HTML 3.2//EN" Cabot Corporation (Form: 8-K)

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 8, 2017

CoverPageTitle END CoverPageRegistrant START

Cabot Corporation ______ (Exact name of registrant as specified in its charter)

Delaware	1-5667	04-2271897
___ (State or other jurisdiction	_______ (Commission	__ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
Two Seaport Lane, Suite 1300, Boston, Massachusetts		02210-2019
_________ (Address of principal executive offices)		_____ (Zip Code)

Registrant’s telephone number, including area code: 617-345-0100

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Cabot Corporation

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

PageBreak START

Top of the Form

PageBreak END Item START

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At its meeting on September 8, 2017, the Board of Directors of Cabot Corporation ("Cabot"), based on the recommendation of the Board’s Governance and Nominating Committee, elected Michael M. Morrow a director of Cabot and appointed Mr. Morrow to the Board’s Audit Committee and Safety, Health and Environmental Affairs Committee, both effective September 8, 2017. Mr. Morrow will serve as a director in the class whose terms expire at the Annual Meeting in 2019. There is no arrangement or understanding between Mr. Morrow and any other person pursuant to which he was selected to become a member of the Board, nor are there any transactions between Mr. Morrow and Cabot or any subsidiary of Cabot that are reportable under Item 404(a) of Regulation S-K. Mr. Morrow will receive compensation for his service as a non-employee director as described under the heading "Director Compensation" in Cabot’s Proxy Statement for the 2017 Annual Meeting of Stockholders, which description is incorporated herein by reference. As part of such compensation, on September 8, 2017, Mr. Morrow was granted 700 shares of Cabot common stock. A copy of the press release announcing Mr. Morrow’s election is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

Brian A. Berube
Name: Brian A. Berube
Title: Senior Vice President and General Counsel

Signature END PageBreak START

Top of the Form

PageBreak END

Exhibit Index

Exhibit No.	Description
99.1	Press Release issued September 11, 2017

HTMLFooter START HTMLFooter END